PAVmed Inc.
PAVM
$0.36
$0.011.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -99.50% | -99.39% | -99.21% | -99.05% | 25.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.50% | -99.39% | -99.21% | -99.05% | 25.92% |
| Cost of Revenue | -96.02% | -97.54% | -97.94% | -97.02% | -22.37% |
| Gross Profit | 87.01% | 94.91% | 96.19% | 93.24% | 61.03% |
| SG&A Expenses | -61.27% | -65.43% | -57.86% | -62.96% | -12.00% |
| Depreciation & Amortization | -- | -- | -- | -100.00% | -83.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -61.44% | -67.80% | -63.75% | -70.19% | -22.95% |
| Operating Income | 58.16% | 65.54% | 61.20% | 68.34% | 25.44% |
| Income Before Tax | -109.90% | 17.37% | 200.60% | 106.56% | 379.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -109.90% | 17.37% | 200.60% | 106.56% | 379.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -82.97% | -90.14% | -89.55% | -91.43% | -9.59% |
| Net Income | -108.36% | -10.10% | 224.69% | 110.20% | 464.43% |
| EBIT | 58.16% | 65.54% | 61.20% | 68.34% | 25.44% |
| EBITDA | 57.48% | 64.92% | 59.83% | 67.31% | 23.35% |
| EPS Basic | -104.57% | 38.25% | 148.66% | 106.27% | 370.29% |
| Normalized Basic EPS | 95.05% | 93.99% | 87.59% | 95.61% | 59.53% |
| EPS Diluted | -120.35% | 37.91% | 112.97% | 99.38% | 160.61% |
| Normalized Diluted EPS | 78.00% | 93.99% | 96.72% | 99.64% | 90.90% |
| Average Basic Shares Outstanding | 115.43% | 97.59% | 59.59% | 34.96% | 34.07% |
| Average Diluted Shares Outstanding | -51.54% | 97.59% | 503.76% | 1,544.77% | 495.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |